NSE BSE
medinova diagnostic services l stock

MEDINOVA DIAGNOSTIC SERVICES L Share Price

- - (%)
- NSE: MEDINOV

MEDINOVA DIAGNOSTIC SERVICES L Share Price Update

As of the latest trading session, MEDINOVA DIAGNOSTIC SERVICES L share price is currently at 34.01, which is down by -1.08 from its previous closing. Today, the stock has fluctuated between 34.00 and 36.00. Over the past year, MEDINOVA DIAGNOSTIC SERVICES L has achieved a return of 40.86 %. In the last month alone, the return has been 0.22 %. Read More...

MEDINOVA DIAGNOSTIC SERVICES L Performance

Day Range

Low34.00 High36.00
34.30

52 Week Range

Low 22.51 High 64.50
34.30

MEDINOVA DIAGNOSTIC SERVICES L Share Price

526301

MEDINOV

img img img img
No Data Available

Open Price

34.60

Prev. Close

35.09

Volume (Shares)

6640.00

Total traded value

2.27

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

MEDINOVA DIAGNOSTIC SERVICES L Fundamentals


(Standalone)

Market Cap (Cr) 33.94
PE Ratio (TTM) 46.79
Book Value / Share -2.04
Beta 0.35
ROE 5.68%
EPS (TTM) 0.75
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.29

MEDINOVA DIAGNOSTIC SERVICES L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 1.92
Operating Expense 1.68
Net Profit 0.29
Net Profit Margin (%) 15.10
Earnings Per Share (EPS) 0.30
EBITDA 0.56
Effective Tax Rate (%) 25.64
Particulars DEC 2023 (Values in Cr)
Revenue 1.82
Operating Expense 1.70
Net Profit 0.12
Net Profit Margin (%) 6.59
Earnings Per Share (EPS) 0.12
EBITDA 0.33
Effective Tax Rate (%) 25.00
Particulars SEP 2023 (Values in Cr)
Revenue 2.22
Operating Expense 1.85
Net Profit 0.30
Net Profit Margin (%) 13.51
Earnings Per Share (EPS) 0.30
EBITDA 0.55
Effective Tax Rate (%) 21.05
Particulars JUN 2023 (Values in Cr)
Revenue 1.82
Operating Expense 1.77
Net Profit 0.04
Net Profit Margin (%) 2.19
Earnings Per Share (EPS) 0.04
EBITDA 0.25
Effective Tax Rate (%) 50.00
Particulars MAR 2023 (Values in Cr)
Revenue 2.15
Operating Expense 1.73
Net Profit 0.42
Net Profit Margin (%) 19.53
Earnings Per Share (EPS) 0.42
EBITDA 0.71
Effective Tax Rate (%) 22.22
Particulars MAR 2024 (Values in Cr)
Revenue 7.78
Operating Expense 7.02
Net Profit 0.75
Net Profit Margin (%) 9.64
Earnings Per Share (EPS) 0.75
EBITDA 1.71
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 7.76
Operating Expense 7.13
Net Profit 0.63
Net Profit Margin (%) 8.11
Earnings Per Share (EPS) 0.63
EBITDA 1.69
Effective Tax Rate (%) 27.58
Particulars MAR 2022 (Values in Cr)
Revenue 11.51
Operating Expense 9.18
Net Profit 2.07
Net Profit Margin (%) 17.98
Earnings Per Share (EPS) 2.08
EBITDA 3.21
Effective Tax Rate (%) 18.82
Particulars MAR 2021 (Values in Cr)
Revenue 11.32
Operating Expense 9.32
Net Profit 2.17
Net Profit Margin (%) 19.16
Earnings Per Share (EPS) 2.17
EBITDA 2.92
Effective Tax Rate (%) 5.67
Particulars MAR 2020 (Values in Cr)
Revenue 5.49
Operating Expense 6.02
Net Profit -0.30
Net Profit Margin (%) -5.46
Earnings Per Share (EPS) -0.30
EBITDA 0.55
Effective Tax Rate (%) -11.11
Particulars MAR 2023 (Values in Cr)
Book Value / Share -5.16
ROE % 15.05
ROCE % 14.61
Total Debt to Total Equity 0.00
EBITDA Margin 28.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share -6.84
ROE % 21.44
ROCE % 19.76
Total Debt to Total Equity 0.00
EBITDA Margin 29.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share -7.23
ROE % 196.40
ROCE % 36.35
Total Debt to Total Equity 0.00
EBITDA Margin 24.65
Particulars MAR 2020 (Values in Cr)
Book Value / Share -9.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 17.05
Particulars MAR 2019 (Values in Cr)
Book Value / Share -8.95
ROE % -111.63
ROCE % 1.83
Total Debt to Total Equity 0.00
EBITDA Margin 15.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.84
ROE % 5.68
ROCE % 8.63
Total Debt to Total Equity 0.00
EBITDA Margin 22.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share -3.48
ROE % 18.65
ROCE % 18.82
Total Debt to Total Equity 0.00
EBITDA Margin 28.32
Particulars MAR 2021 (Values in Cr)
Book Value / Share -5.58
ROE % 126.53
ROCE % 44.50
Total Debt to Total Equity 0.00
EBITDA Margin 25.80
Particulars MAR 2020 (Values in Cr)
Book Value / Share -7.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 10.20
Particulars MAR 2019 (Values in Cr)
Book Value / Share -7.41
ROE % -7.48
ROCE % -0.43
Total Debt to Total Equity 0.00
EBITDA Margin 7.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.31
Total Assets 4.44
Total Liabilities 4.44
Total Equity -6.80
Share Outstanding 9981640
Price to Book Ratio -9.08
Return on Assets (%) 51.08
Return on Capital (%) -534.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 4.37
Total Liabilities 4.37
Total Equity -7.50
Share Outstanding 9981640
Price to Book Ratio -4.10
Return on Assets (%) 46.24
Return on Capital (%) -66.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 4.05
Total Liabilities 4.05
Total Equity -9.36
Share Outstanding 9981640
Price to Book Ratio -1.84
Return on Assets (%) -6.36
Return on Capital (%) 6.41
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 4.77
Total Liabilities 4.77
Total Equity -9.13
Share Outstanding 9956840
Price to Book Ratio -3.52
Return on Assets (%) 17.24
Return on Capital (%) -25.22
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 6.07
Total Liabilities 6.07
Total Equity -9.93
Share Outstanding 9956840
Price to Book Ratio 0.00
Return on Assets (%) -7.45
Return on Capital (%) 10.17
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 6.33
Total Liabilities 6.33
Total Equity -2.83
Share Outstanding 9981640
Price to Book Ratio -6.18
Return on Assets (%) 9.94
Return on Capital (%) 21.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.30
Total Assets 6.68
Total Liabilities 6.68
Total Equity -3.46
Share Outstanding 9981640
Price to Book Ratio -9.08
Return on Assets (%) 31.02
Return on Capital (%) 90.91
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 4.63
Total Liabilities 4.63
Total Equity -5.55
Share Outstanding 9981640
Price to Book Ratio -4.10
Return on Assets (%) 46.74
Return on Capital (%) -94.83
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 4.02
Total Liabilities 4.02
Total Equity -7.67
Share Outstanding 9981640
Price to Book Ratio -1.84
Return on Assets (%) -7.35
Return on Capital (%) 8.1
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 4.19
Total Liabilities 4.19
Total Equity -7.37
Share Outstanding 9956840
Price to Book Ratio -3.52
Return on Assets (%) 18.28
Return on Capital (%) -22.18
Particulars MAR 2023 (Values in Cr)
Net Income 1.90
Cash from Operations 1.49
Cash from Investing -0.33
Cash from Financing -0.85
Net change in Cash 0.22
Free Cash Flow 1.88
Particulars MAR 2022 (Values in Cr)
Net Income 2.79
Cash from Operations 1.85
Cash from Investing -1.83
Cash from Financing 0.31
Net change in Cash -0.17
Free Cash Flow 2.02
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 1.66
Cash from Investing -0.06
Cash from Financing -1.37
Net change in Cash 0.24
Free Cash Flow 1.84
Particulars MAR 2020 (Values in Cr)
Net Income -0.27
Cash from Operations 1.27
Cash from Investing -0.15
Cash from Financing -1.07
Net change in Cash 0.00
Free Cash Flow 1.29
Particulars MAR 2019 (Values in Cr)
Net Income 1.08
Cash from Operations 1.62
Cash from Investing -0.14
Cash from Financing -1.20
Net change in Cash -0.05
Free Cash Flow 1.77
Particulars MAR 2023 (Values in Cr)
Net Income 0.87
Cash from Operations 1.25
Cash from Investing -0.33
Cash from Financing -0.78
Net change in Cash 0.06
Free Cash Flow 1.64
Particulars MAR 2022 (Values in Cr)
Net Income 2.55
Cash from Operations 1.63
Cash from Investing -1.83
Cash from Financing 0.94
Net change in Cash 0.23
Free Cash Flow 1.80
Particulars MAR 2021 (Values in Cr)
Net Income 2.29
Cash from Operations 1.47
Cash from Investing -0.11
Cash from Financing -1.15
Net change in Cash 0.24
Free Cash Flow 1.66
Particulars MAR 2020 (Values in Cr)
Net Income -0.26
Cash from Operations 0.49
Cash from Investing -0.14
Cash from Financing -0.26
Net change in Cash 0.01
Free Cash Flow 0.49
Particulars MAR 2019 (Values in Cr)
Net Income 1.10
Cash from Operations 0.84
Cash from Investing -0.13
Cash from Financing -0.43
Net change in Cash -0.04
Free Cash Flow 1.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
MEDINOVA DIAGNOSTIC SERVICES L 35.09 17.55 -11.30 35.03 22.51 / 64.50
APOLLO HOSPITALS ENTER. L 6454.95 103.43 13.39 92812.28 4727.00 / 6871.30
FORTIS MALAR HOSPITALS LIMITED 66.30 0.00 1.13 124.26 44.00 / 107.94
SHREE PACETRONIX LTD. 182.30 19.54 5.03 65.62 138.00 / 391.90
TRANSGENE BIOTEK LTD. 10.08 0.00 7.13 76.38 3.62 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
MEDINOVA DIAGNOSTIC SERVICES L 35.09 46.79 -17.18 35.03 22.51 / 64.50
APOLLO HOSPITALS ENTER. L 6454.95 91.85 12.03 92812.28 4727.00 / 6871.30
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 35.99 0.00 -81.46 26.88 21.00 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 4254.85 25.86 5.23 4654.81 2377.20 / 4777.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 36.00
  • 26 Days 38.10
  • 10 Days 38.00
  • 50 Days 38.10
  • 12 Days 38.50
  • 100 Days 37.00
  • 20 Days 37.80
  • 200 Days 29.30
35.70
PIVOT
First Resistance 36.89
Second Resistance 38.70
Third Resistance 39.89
First Support 33.89
Second Support 32.70
Third Support 30.89
RSI 47.65
MACD 0.43
Commodity Channel Index (CCI) -63.90
ADX 20.49
Williams % R -94.27

Over 1 Month

down

0.22

Over 3 Months

down

2.54

Over 6 Months

down

-31.51

Over 1 Year

down

40.86

Over 3 Years

down

-1.97

Over 5 Years

down

18.92

MEDINOVA DIAGNOSTIC SERVICES L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MEDINOVA DIAGNOSTIC SERVICES L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
37.86
Promoter Holdings
62.13
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Vijaya Diagnostic Centre Limited Shareholding of Promoter and Promoter Group 6202220.0 62.14
Shankar Lal Saraf Public Shareholding 326500.0 3.27
Subba Lakshmi Champati Public Shareholding 299824.0 3.0
Kattamreddy Lakshminarayana Reddy Public Shareholding 125000.0 1.25
Padarthi Harinadha Reddy Public Shareholding 125000.0 1.25
Duvvuru Jalandhar Reddy Public Shareholding 100000.0 1.0
Muddu Krishna Reddy Oduru Public Shareholding 100000.0 1.0

MEDINOVA DIAGNOSTIC SERVICES L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MEDINOVA DIAGNOSTIC SERVICES L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MEDINOVA DIAGNOSTIC SERVICES L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Medinova Diagnostic Services Ltd?

Answer Field

The share price of Medinova Diagnostic Services Ltd for NSE is ₹ 0.00 and for BSE is ₹ 34.90.

What is the Market Cap of Medinova Diagnostic Services Ltd?

Answer Field

The market cap of Medinova Diagnostic Services Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 34.80 Cr. as of now.

What is the 52 Week High and Low of Medinova Diagnostic Services Ltd?

Answer Field

The 52 Week High and Low of Medinova Diagnostic Services Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 64.50 and ₹ 22.51.

How to Buy Medinova Diagnostic Services Ltd share?

Answer Field

You can trade in Medinova Diagnostic Services Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medinova Diagnostic Services Ltd?

Answer Field

The 1 year returns on the stock has been 43.95%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader